Prednistab Patent Expiration

Prednistab Petitions

Details of Prednistab's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
Tyler Group, Inc Approved 21 Mar, 2000 The proposed generic product will have a dosage form as a palatable chewable tablet as opposed to the pioneer product which is a tablet.

About Prednistab

Prednistab is a drug owned by LLOYD, INC. Prednistab uses Prednisolone as the active ingredient.

Active Ingredient:

Prednistab uses Prednisolone as the active ingredient. Check out other Drugs and Companies using Prednisolone ingredient.